Initial Evaluation of Anti-1-amino-F-18 Flurocyclobutane-1carboxylic Acid (Anti-18F-FACBC) in the Assessment of Head and Neck Cancer: A Pilot Study.
Phase of Trial: Phase 0
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Head and neck cancer
- Focus Diagnostic use
- 03 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 31 Mar 2018.
- 04 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Mar 2017.
- 09 Aug 2016 Status changed from recruiting to suspended due to change in principal investigator, revising the study.